Comparison of Systematic, Targeted and Combined Prostate Biopsy: Our Clinical Outcomes

Basit Öğe Kaydı
dc.contributor.authorŞenoglu, Yusuf
dc.contributor.authorTaşkıran, Arda Taşkın
dc.contributor.authorYüksel, Alpaslan
dc.contributor.authorBaba, Dursun
dc.date.accessioned2024-08-23T16:08:14Z
dc.date.available2024-08-23T16:08:14Z
dc.date.issued2022en_US
dc.departmentDüzce Üniversitesien_US
dc.description.abstractObjective: Our aim was to compare the diagnostic efficacy of the standard systematic, targeted and combined prostate biopsy methods in prostate cancer. Materials and Methods: Total of 161 patients who underwent prostate biopsy combined with magnetic resonance imaging-ultrasonography fusion method between August 2018 and March 2021 was evaluated retrospectively. Clinically important and insignificant cancer detection rates of biopsy results between standard, targeted and combined biopsy (CB) methods were compared. Changes in the results were also evaluated in terms of Prostate Imaging-Reporting and Data System (PIRADS) scores. Results: Prostate cancer was diagnosed in 46 (28.6%) patients by CB. Fourteen (8.7%) patients were interpreted as a clinically insignificant disease. Prostate cancer and clinically significant disease detection rates were statistically significant in favor of CB compared to targeted biopsy (TB). There was no statistically significant difference between systematic biopsy and TB results. Additionally, it was observed that cancer detection rates were higher in PIRADS ?4 lesions compared to PIRADS 3 lesions in all biopsy methods. Conclusions: Our results have shown that combined prostate biopsy led to higher detection of prostate cancer and provides increased detection of clinically significant disease. High rates of clinically significant cancer, especially in patients with PIRADS ?4 lesions, suggest that the PIRADS scoring is a high-level guide in detecting malignancy.en_US
dc.identifier.doi10.4274/uob.galenos.2021.2021.4.1
dc.identifier.endpage44en_US
dc.identifier.issn2147-2122
dc.identifier.issue2en_US
dc.identifier.startpage40en_US
dc.identifier.trdizinid1172145en_US
dc.identifier.urihttps://search.trdizin.gov.tr/tr/yayin/detay/1172145
dc.identifier.urihttps://hdl.handle.net/20.500.12684/15186
dc.identifier.volume21en_US
dc.indekslendigikaynakTR-Dizinen_US
dc.language.isoenen_US
dc.relation.ispartofÜroonkoloji Bültenien_US
dc.relation.publicationcategoryMakale - Ulusal Hakemli Dergi - Kurum Öğretim Elemanıen_US
dc.rightsinfo:eu-repo/semantics/openAccessen_US
dc.titleComparison of Systematic, Targeted and Combined Prostate Biopsy: Our Clinical Outcomesen_US
dc.typeArticleen_US

Dosyalar

Orijinal paket
Listeleniyor 1 - 1 / 1
Küçük Resim
İsim:
15186.pdf
Boyut:
124.95 KB
Biçim:
Adobe Portable Document Format
İndir

Koleksiyon

TR-Dizin İndeksli Yayınlar Koleksiyonu